Proteomics International Partners with inVentiv Health Clinical
Proteomics International Partners with inVentiv Health Clinical
Proteomics International, a pretomics laboratory, has signed a collaborative agreement with inVentiv Health Clinical, provider of global research and bioanalytical services, with the intention of helping streamline the process from characterization to clinical trials.
Proteomics International's structural characterization and QC testing of proposed and referenced products with an advanced suite of scientific instrumentation complement inVentiv Health’s array of bioanalytical capabilities from clinical development through commercialization in support of biosimilar development.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
